Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $105 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].

Ritika Mahal

Ritika Mahal

Associate
Life Sciences
Boston

Experience

Ms. Mahal joined Bain Capital Life Sciences in 2018. She is an Associate.

Prior to joining Bain Capital Life Sciences, Ms. Mahal spent several years across different functions at Biogen: Global Commercial Strategy, Corporate Development and Strategy, and Research and Development Strategy. As part of these functions, Ms. Mahal was responsible for M&A landscapes and prioritization, due diligence, corporate growth strategy, therapeutic and disease area strategies, and portfolio prioritization and governance. 


Education

Ms. Mahal graduated with high honors from Boston University Healthcare Management Program. She received an MS in Molecular Biology from the International Max Planck Research School at University of Göttingen and a BS in Biotechnology from Guru Gobind Singh Indraprastha University, Delhi.